JEOL Ltd. (JELLF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
JEOL Ltd. (JELLF) trades at $40.78 with AI Score 54/100 (Grade B). JEOL Ltd. specializes in scientific and metrology instruments, semiconductor and industrial equipment, and medical equipment. Market cap: $1.99B, Sector: Technology.
Price live · AI analysis from Mar 16, 2026Analyst Coverage for JELLF: JELLF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates JELLF against Technology peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
JELLF: 4/7 perspectives are bullish. Dominant signal: Ken Griffin bullish.
How is this calculated? →JEOL Ltd. (JELLF) Technology Profile & Competitive Position
JEOL Ltd., established in 1949, is a global technology leader specializing in scientific and metrology instruments, semiconductor equipment, and medical devices. With a market capitalization of $1.99B, the company serves diverse industries through its advanced electron microscopes, mass spectrometers, and industrial equipment, maintaining a solid 8.5% profit margin.
What Is the Investment Thesis for JELLF?
JEOL Ltd. presents a compelling investment case based on its established market position and diverse product portfolio. With a market capitalization of $1.99B and a P/E ratio of 14.5, the company demonstrates financial stability and growth potential. Key value drivers include sustained demand for its scientific and metrology instruments, driven by advancements in nanotechnology and materials science. The company's 8.5% profit margin and 46.0% gross margin reflect efficient operations and pricing power. Growth catalysts include expansion into emerging markets and continued innovation in electron microscopy and mass spectrometry. However, potential risks include fluctuations in semiconductor industry demand and competition from other scientific instrument manufacturers. The company's beta of 0.91 suggests moderate volatility relative to the market. The dividend yield of 1.67% provides a steady income stream for investors. Overall, JEOL's diversified business model and commitment to innovation position it for long-term growth and value creation.
Based on FMP financials and quantitative analysis
JELLF Key Highlights
- Market capitalization of $1.99B indicates substantial investor confidence and market valuation.
- P/E ratio of 14.5 suggests a reasonable valuation relative to earnings.
- Profit margin of 8.5% demonstrates efficient operations and profitability.
- Gross margin of 46.0% reflects strong pricing power and cost management.
- Dividend yield of 1.67% provides a steady income stream for investors.
Who Are JELLF's Competitors?
JELLF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| AITUF Anritsu Corporation | $26.18 | -5.52% | $3.35B | 51 |
| AMANF Amano Corporation | $24.86 | -1.04% | $1.72B | 56 |
| APELF Alps Alpine Co., Ltd. | $10.00 | +0.00% | $1.95B | 45 |
| ASAAF AT & S Austria Technologie & Systemtechnik AG | $223.40 | +3.23% | $13.69B | 49 |
| DNACF DeNA Co., Ltd. | $16.00 | +0.00% | $1.72B | 54 |
| MDA Macdonald Dettwiler & Associate | $42.11 | +3.34% | 6B | 66 |
| WATT Energous Corporation | $19.29 | -19.93% | $28.65M | 65 |
| SELX Selecta Biosciences, Inc. | $0.34 | +580.00% | $12.78M | 64 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are JELLF's Key Strengths?
- Strong brand reputation in scientific and industrial equipment markets.
- Diverse product portfolio across scientific, semiconductor, and medical sectors.
- Global distribution network and established customer base.
- Technological expertise in electron optics and related technologies.
What Are JELLF's Weaknesses?
- Dependence on cyclical industries, such as semiconductors.
- Limited brand recognition in consumer markets.
- Exposure to currency fluctuations due to global operations.
- Potential for product obsolescence due to rapid technological advancements.
What Could Drive JELLF Stock Higher?
- Increasing demand for advanced materials characterization in nanotechnology and materials science.
- Expansion of the semiconductor industry driving demand for advanced manufacturing equipment.
- Potential new product launches in electron microscopy and mass spectrometry in Q4 2026.
- Growing adoption of clinical chemistry analyzers in emerging markets.
- Recurring revenue from service and maintenance contracts providing a stable income stream.
What Are the Key Risks for JELLF?
- Economic downturns that reduce capital spending by research institutions and manufacturers.
- Intense competition from established players in the scientific and industrial equipment markets.
- Regulatory changes that impact the use of scientific instruments and medical devices.
- Disruptive technologies that could render existing products obsolete.
- Fluctuations in currency exchange rates impacting profitability due to global operations.
What Are the Growth Opportunities for JELLF?
- Expansion in Nanotechnology: JEOL can capitalize on the growing nanotechnology market, projected to reach $125 billion by 2028. The company's electron microscopes and surface analysis instruments are essential for characterizing nanomaterials, providing a significant growth opportunity. By investing in R&D and expanding its product offerings in this area, JEOL can strengthen its position as a key enabler of nanotechnology advancements.
- Semiconductor Equipment Market: The semiconductor equipment market is expected to grow significantly, driven by the increasing demand for advanced chips. JEOL's thin-film formation and material processing equipment are critical for semiconductor manufacturing. By focusing on developing cutting-edge solutions for advanced packaging and 3D integration, JEOL can capture a larger share of this expanding market.
- Medical Equipment Advancements: The global clinical chemistry analyzer market is projected to reach $15 billion by 2027. JEOL's clinical chemistry analyzers play a vital role in diagnostics and healthcare. By investing in the development of more advanced and automated analyzers, JEOL can expand its presence in the medical equipment market and contribute to improved healthcare outcomes.
- Emerging Markets Growth: Emerging markets, particularly in Asia-Pacific, are experiencing rapid growth in research and development spending. JEOL can leverage its global presence and established distribution network to expand its sales in these regions. By tailoring its product offerings to meet the specific needs of emerging market customers, JEOL can unlock significant growth opportunities.
- Service and Maintenance Revenue: JEOL generates recurring revenue from the service and maintenance of its installed base of instruments and equipment. By expanding its service offerings and providing comprehensive support to its customers, JEOL can increase its service revenue stream. This includes offering preventative maintenance programs, training, and technical support to ensure the optimal performance of its products.
What Opportunities Does JELLF Have?
- Expansion in emerging markets with growing R&D spending.
- Increased demand for nanotechnology and advanced materials characterization.
- Development of new applications for electron microscopy and mass spectrometry.
- Strategic acquisitions to expand product portfolio and market reach.
What Threats Does JELLF Face?
- Intense competition from established players in the scientific and industrial equipment markets.
- Economic downturns that reduce capital spending by research institutions and manufacturers.
- Regulatory changes that impact the use of scientific instruments and medical devices.
- Disruptive technologies that could render existing products obsolete.
What Are JELLF's Competitive Advantages?
- Technological Expertise: JEOL has a long history of innovation in electron optics and related technologies, providing a competitive edge in developing advanced instruments and equipment.
- Established Brand Reputation: The JEOL brand is well-recognized and respected in the scientific community, built on decades of providing high-quality and reliable products.
- Global Distribution Network: JEOL has a global network of subsidiaries and distributors, enabling it to serve customers in various regions and provide local support.
- High Switching Costs: The complexity and cost of JEOL's instruments and equipment create high switching costs for customers, making them less likely to switch to competitors.
- Strong Customer Relationships: JEOL has cultivated strong relationships with its customers through its commitment to providing excellent service and support.
What Does JELLF Do?
JEOL Ltd., originally founded as Japan Electron Optics Laboratory Co., Ltd. in 1949, has evolved into a global leader in the design, manufacture, and marketing of high-technology instruments and equipment. Headquartered in Akishima, Japan, the company's initial focus on electron optics has expanded to encompass a wide range of scientific and industrial solutions. JEOL's core business revolves around three primary segments: scientific and metrology instruments, semiconductor and industrial equipment, and medical equipment. Its scientific instrument offerings include transmission electron microscopes (TEM), scanning electron microscopes (SEM), mass spectrometers, and nuclear magnetic resonance (NMR) spectrometers, which are essential tools for research and development in materials science, nanotechnology, and biotechnology. The semiconductor and industrial equipment segment provides solutions for thin-film formation, material processing, and electron beam lithography, supporting the manufacturing of semiconductors and other advanced materials. The medical equipment division focuses on clinical chemistry analyzers, contributing to advancements in diagnostics and healthcare. JEOL's global presence is supported by a network of subsidiaries and distributors, enabling it to serve customers in various regions. The company's commitment to innovation and quality has established it as a trusted partner for researchers, manufacturers, and healthcare providers worldwide. With a workforce of 3,435 employees, JEOL continues to invest in research and development to maintain its competitive edge and address emerging market needs.
What Products and Services Does JELLF Offer?
- Develops and manufactures transmission electron microscopes for advanced materials research.
- Produces scanning electron microscopes used in nanotechnology and semiconductor industries.
- Offers ion beam application equipment for specimen preparation and material processing.
- Provides instruments for microarea and surface analysis, including electron probe micro analyzers.
- Manufactures magnetic resonance equipment, such as nuclear magnetic resonance spectrometers.
- Offers X-ray fluorescence spectrometers for elemental analysis.
- Develops mass spectrometers for chemical and biological analysis.
- Produces electron beam lithography systems for semiconductor manufacturing.
How Does JELLF Make Money?
- Direct sales of scientific and metrology instruments to research institutions and universities.
- Sales of semiconductor and industrial equipment to manufacturers in the semiconductor and materials processing industries.
- Sales of medical equipment, including clinical chemistry analyzers, to hospitals and clinical laboratories.
- Recurring revenue from service and maintenance contracts for its installed base of equipment.
- Sales of spare parts and consumables for its instruments and equipment.
What Industry Does JELLF Operate In?
JEOL Ltd. operates within the scientific instruments and semiconductor equipment industry, which is characterized by rapid technological advancements and increasing demand for high-precision instruments. The global scientific instruments market is projected to reach $40 billion by 2028, driven by growth in research and development spending, particularly in biotechnology and nanotechnology. The semiconductor equipment market is also experiencing strong growth, fueled by the increasing demand for semiconductors in various applications, including consumer electronics, automotive, and industrial automation. JEOL competes with companies like AITUF (Advanced Industrial Technology), AMANF (ASM International), and APELF (Applied Materials) in providing advanced equipment solutions. The company's competitive advantage lies in its expertise in electron optics and its ability to offer a comprehensive range of instruments and equipment.
Who Are JELLF's Key Customers?
- Research institutions and universities conducting materials science, nanotechnology, and biotechnology research.
- Semiconductor manufacturers producing integrated circuits and other electronic components.
- Industrial companies involved in material processing and thin-film deposition.
- Hospitals and clinical laboratories performing diagnostic testing.
- Government agencies and regulatory bodies involved in scientific research and quality control.
FY2027 estForward Outlook
Wall Street analysts project JEOL Ltd. revenue of about $166.64B for fiscal 2027, with EPS near $427.17. The estimate reflects 4 contributing analysts.
JELLF Valuation & Market Position
With a $1.99B market cap, JEOL Ltd. sits in the small-cap segment of the market. Relative to its peer group, JELLF's quantitative score of 54/100 is roughly in line with the peer average of 51/100.
ROE 15%Key Financial Metrics
Return on equity for JEOL Ltd. stands at 15.4%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 9.1%, showing how much profit it generates from its asset base. JELLF trades at a trailing price-to-earnings ratio of 14.49, below the Technology sector average of ~38x. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 2.15 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 5.6%, the inverse of the P/E and a quick read on earnings relative to price.
F-Score 4/9Financial Health
JEOL Ltd.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 4.12 places it in the safe zone, indicating low near-term bankruptcy risk.
Company Profile
JEOL Ltd. operates in the Hardware, Equipment & Parts industry within the Technology sector. It is headquartered in Akishima, JP. The company is led by CEO Izumi Oi. JELLF has traded publicly since 2020.
JELLF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in the company's future, indicating a strong belief in its growth potential.
- Community sentiment has shifted positively, with discussions highlighting innovative product developments that could enhance market share.
- Analysts have noted increased demand for JEOL's scientific instruments, positioning the company well in a growing sector.
- Market perception is bolstered by successful collaborations and partnerships that enhance the company's credibility and reach.
Bear Case
- Concerns over supply chain disruptions have emerged, which could impact production timelines and operational efficiency.
- Negative sentiment from some community members revolves around competition in the scientific instrument market, raising doubts about market positioning.
- Recent quarterly reports indicated slower-than-expected sales growth, leading to skepticism about the company's short-term performance.
- Economic uncertainties and potential budget cuts in research funding could pose risks to JEOL's revenue streams.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
JELLF Latest News
-
New Polymorph of Indomethacin Discovered
Yahoo! Finance: JELLF News · Jun 9, 2026
-
JEOL: Sales Launch of the Laser SEM System "LazEdge"
Yahoo! Finance: JELLF News · May 25, 2026
JELLF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for JELLF.
Price Targets
Wall Street price target analysis for JELLF.
JELLF MoonshotScore
What does this score mean?
The MoonshotScore rates JELLF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Classification
Industry Hardware, Equipment & PartsLeadership: Izumi Oi
CEO
Izumi Oi serves as the CEO of JEOL Ltd., overseeing the company's global operations and strategic direction. His career spans several decades in the technology and manufacturing sectors. Prior to becoming CEO, he held various leadership positions within JEOL, including roles in product development, marketing, and sales. He holds a degree in Engineering from a leading Japanese university and has extensive experience in the design and manufacturing of scientific instruments and semiconductor equipment.
Track Record: Under Izumi Oi's leadership, JEOL has focused on expanding its presence in emerging markets and investing in research and development to maintain its technological edge. He has overseen the launch of several new products, including advanced electron microscopes and mass spectrometers. His strategic decisions have contributed to the company's sustained growth and profitability. He manages 3435 employees.
JELLF OTC Market Information
The OTC Other tier, where JELLF trades, represents the lowest tier of the OTC market. Companies in this tier often have limited or no financial disclosure and may not meet minimum financial standards. Unlike stocks listed on major exchanges like the NYSE or NASDAQ, OTC Other stocks face fewer regulatory requirements, resulting in higher information asymmetry and increased risk for investors. This tier is often populated by shell companies, bankrupt entities, or companies with questionable operations, requiring investors to exercise extreme caution.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited Financial Disclosure: The lack of publicly available financial information makes it difficult to assess the company's financial health and operational performance.
- Low Liquidity: Low trading volume and wide bid-ask spreads can make it challenging to buy or sell shares at desired prices.
- Regulatory Scrutiny: OTC stocks are subject to less regulatory oversight than stocks listed on major exchanges, increasing the risk of fraud and market manipulation.
- Potential for Delisting: JELLF could be delisted from the OTC market if it fails to meet minimum listing requirements or comply with regulatory standards.
- Information Asymmetry: The lack of transparency and limited information available to investors creates information asymmetry, which can disadvantage retail investors.
- Verify the company's legal status and registration with relevant regulatory authorities.
- Obtain and review audited financial statements to assess the company's financial health.
- Research the background and experience of the company's management team.
- Evaluate the company's business model and competitive landscape.
- Assess the liquidity and trading volume of the stock on the OTC market.
- Consult with a qualified financial advisor to assess the risks and potential rewards of investing in JELLF.
- Determine if the company is a 'dark' or 'defunct' company.
- Established History: JEOL Ltd. has been in operation since 1949, suggesting a degree of stability and experience in its industry.
- Global Presence: The company has a global network of subsidiaries and distributors, indicating a significant market presence.
- Diverse Product Portfolio: JEOL offers a wide range of scientific and industrial equipment, reducing its dependence on any single product or market.
- Technological Expertise: The company has a long history of innovation in electron optics and related technologies, providing a competitive edge.
JEOL Ltd. Technology Stock: Key Questions Answered
What does JEOL Ltd. do?
JEOL Ltd. is a global technology leader specializing in the development, manufacture, and marketing of scientific and metrology instruments, semiconductor and industrial equipment, and medical equipment. Its core offerings include electron microscopes, mass spectrometers, NMR spectrometers, and clinical chemistry analyzers. These products serve a diverse range of industries, including materials science, nanotechnology, semiconductor manufacturing, and healthcare. The company's business model is based on direct sales, service contracts, and sales of spare parts and consumables, generating revenue from both capital equipment and recurring services.
What are the main risks for JELLF?
JEOL Ltd. faces several risks, including dependence on cyclical industries such as semiconductors, intense competition from established players, and potential regulatory changes impacting the use of its products. Economic downturns can reduce capital spending by research institutions and manufacturers, impacting demand for JEOL's equipment. Disruptive technologies could also render existing products obsolete. Operating on the OTC market introduces additional risks, including limited financial disclosure and low liquidity.
What are the key factors to evaluate for JELLF?
JEOL Ltd. (JELLF) holds an AI score of 54/100 (moderate). P/E: 14.5x vs the S&P 500's ~20-25x. Not financial advice.
How frequently does JELLF data refresh on this page?
JELLF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven JELLF's recent stock price performance?
JEOL Ltd. (JELLF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Strong brand reputation in scientific and industrial equipment markets. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider JELLF overvalued or undervalued right now?
JEOL Ltd. (JELLF) trades at 14.5x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying JELLF?
Before investing in JEOL Ltd. (JELLF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding JELLF to a portfolio?
Key strength of JEOL Ltd. (JELLF): Strong brand reputation in scientific and industrial equipment markets. Weigh rewards against risks and diversify. Not financial advice.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- OTC data may be less reliable than exchange-listed data.
- AI analysis pending may impact overall assessment.